cardiomyopathy
In the adult heart, cardiac GRK2 is a major factor regulating inotropic and lusitropic tachyphylaxis to beta-adrenergic agonist, which likely contributes to its protective effects in catecholamine cardiomyopathy.
In the adult heart, cardiac <span class="gene" id="17008600-10-28-32">GRK2</span> is a major factor regulating inotropic and lusitropic tachyphylaxis to beta-adrenergic agonist, which likely contributes to its protective effects in catecholamine <span class="disease" id="17008600-10-197-211">cardiomyopathy</span>.